Learn More
OBJECTIVE To evaluate subcutaneous SBI-087 to treat rheumatoid arthritis (RA). METHODS A total of 210 adult patients with active RA were randomized to receive either 200 mg SBI-087 or placebo(More)
OBJECTIVES To assess the validity of the rheumatoid arthritis impact of disease (RAID) for measuring disease activity of rheumatoid arthritis (RA) and to determine cut-off values for defining the(More)
  • 1